Page 133 - 2020_01-Haematologica-web

Intraclonal heterogeneity in CMML
among human induced pluripotent stem cell
lines. Blood. 2013;122(12):2047-2052.
17. Welch RP, Lee C, Imbriano PM, et al. ChIP- Enrich: gene set enrichment testing for ChIP-seq data. Nucleic Acids Res.
2014;42(13):e105-e105.
18. Chang CJ, Kotini AG, Olszewska M, et al.
Dissecting the contributions of cooperating gene mutations to cancer phenotypes and drug responses with patient-derived iPSCs. Stem Cell Reports. 2018;10(5):1610-1624.
19. Oakes CC, Claus R, Gu L, et al. Evolution of DNA methylation is linked to genetic aber- rations in chronic lymphocytic leukemia. Cancer Discov. 2014;4(3):348-361.
20. Mazor T, Pankov A, Song JS, Costello JF. Intratumoral heterogeneity of the epigenome. Cancer Cell. 2016;29(4):440- 451.
21. Pan H, Jiang Y, Boi M, et al. Epigenomic evo- lution in diffuse large B-cell lymphomas. Nat Commun. 2015;6(1):6921.
22. Park Y, Figueroa ME, Rozek LS, Sartor MA. MethylSig: a whole genome DNA methyla-
tion analysis pipeline. Bioinformatics.
2014;30(17):2414-2422.
23. Akalin A, Garrett-Bakelman FE,
Kormaksson M, et al. Base-pair resolution DNA methylation sequencing reveals pro- foundly divergent epigenetic landscapes in acute myeloid leukemia. PLoS Genet. 2012;8(6):e1002781.
24. Roerink SF, Sasaki N, Lee-Six H, et al. Intra- tumour diversification in colorectal cancer at the single-cell level. Nature. 2018;556(7702): 457-462.
25. Nault JC, Mallet M, Pilati C, et al. High fre- quency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellu- lar carcinoma and preneoplastic lesions. Nat Commun. 2013;4(1):2218.
26. Cahan P, Daley GQ. Origins and implica- tions of pluripotent stem cell variability and heterogeneity. Nat Rev Mol Cell Biol. 2013;14(6):357-368.
27. Nishizawa M, Chonabayashi K, Nomura M, et al. Epigenetic variation between human induced pluripotent stem cell lines is an indi-
cator of differentiation capacity. Cell Stem
Cell. 2016;19(3):341-354.
28. Kwon EM, Connelly JP, Hansen NF, et al.
iPSCs and fibroblast subclones from the same fibroblast population contain compa- rable levels of sequence variations. Proc Natl Acad Sci U S A. 2017;114(8):1964-1969.
29. Yoshizato T, Dumitriu B, Hosokawa K, et al. Somatic mutations and clonal hemato- poiesis in aplastic anemia. N Engl J Med. 2015;373(1):35-47.
30. Naik SH, Perie L, Swart E, et al. Diverse and heritable lineage imprinting of early haematopoietic progenitors. Nature. 2013;496(7444):229-232.
31. Velten L, Haas SF, Raffel S, et al. Human haematopoietic stem cell lineage commit- ment is a continuous process. Nat Cell Biol. 2017;19(4):271-281.
32. Marusyk A, Tabassum DP, Altrock PM, Almendro V, Michor F, Polyak K. Non-cell- autonomous driving of tumour growth sup- ports sub-clonal heterogeneity. Nature. 2014;514(7520):54-58.
haematologica | 2020; 105(1)
123